CRISPR THERAPEUTICS AG's ticker is CRSP and the CUSIP is H17182108. A total of 443 filers reported holding CRISPR THERAPEUTICS AG in Q4 2021. The put-call ratio across all filers is 1.13 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,818,525 | -51.8% | 32,624 | -91.8% | 1.30% | -63.6% |
| Q2 2023 | $22,456,000 | -10.9% | 400,000 | +77.6% | 3.58% | +101.5% |
| Q3 2021 | $25,215,000 | -51.3% | 225,268 | -29.5% | 1.78% | -57.6% |
| Q2 2021 | $51,759,000 | +645.5% | 319,711 | +461.1% | 4.18% | +1688.5% |
| Q1 2021 | $6,943,000 | -60.7% | 56,984 | -50.6% | 0.23% | -69.9% |
| Q4 2020 | $17,654,000 | +83.1% | 115,300 | 0.0% | 0.78% | +11.5% |
| Q3 2020 | $9,644,000 | -26.7% | 115,300 | -35.6% | 0.70% | -33.3% |
| Q2 2020 | $13,162,000 | +73.3% | 179,100 | 0.0% | 1.05% | +83.4% |
| Q1 2020 | $7,596,000 | +0.8% | 179,100 | +44.8% | 0.57% | -53.2% |
| Q4 2019 | $7,534,000 | – | 123,700 | – | 1.22% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 498,558 | $27,989,046 | 33.20% |
| Gilfoyle Management LLC | 100 | $4,842 | 15.90% |
| NEA Management Company, LLC | 1,587,854 | $89,142,124 | 6.80% |
| ARK Investment Management | 7,338,447 | $411,980,394 | 2.73% |
| Nikko Asset Management Americas, Inc. | 3,533,357 | $198,327,328 | 2.09% |
| Del-Sette Capital Management, LLC | 33,661 | $1,889,729 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Ikarian Capital, LLC | 200,000 | $11,228,000 | 1.79% |
| Merlin Capital, Inc | 8,802 | $494,144 | 1.67% |
| Green Alpha Advisors, LLC | 34,373 | $1,929,700 | 1.27% |